FBXW11 and non-small cell lung carcinoma: In non-small-cell lung cancer (NSCLC), miR-182 acts an oncogenic role and fosters cell proliferation by directly targeting FBXW7 and FBXW11, indicating that miR-182 may be a fresh diagnostic and prognostic biomarker of NSCLC [13].